Pinnacle Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Pinnacle Associates's BSX Position: Q3 2026 in Review
Pinnacle Associates increased its Boston Scientific (BSX) stake by 27% in Q3 2026, buying an estimated $207K and bringing the position to 21,182 shares worth $925K. The position accounts for 0.01% of the portfolio, ranked #548.
Pinnacle Associates first reported a position in BSX in Q3 2022 and has held it in 17 quarters since. 545 funds tracked by Wall St. Rank hold BSX as of Q3 2026.
- Pinnacle Associates held 21,182 shares of Boston Scientific worth $925K as of Q3 2026.
- Pinnacle Associates bought 4,469 Boston Scientific shares in Q3 2026, an estimated $207K.
- Boston Scientific made up 0.01% of Pinnacle Associates's portfolio in Q3 2026, its #548 holding.
- Pinnacle Associates first reported a position in Boston Scientific in Q3 2022 and has held it in 17 quarters since.
- 545 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.
Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.